Remove Containment Remove Contamination Remove Hormones Remove Regulation
article thumbnail

HPAPIs – Current Interest of the Pharmaceutical Industry

Roots Analysis

This has led to their widespread production and extensive use in the treatment of various indications including hormonal imbalances, oncological disorders and respiratory disorders. Hormones: Biologic HPAPIs which are not classified as oncology drugs include hormones, narcotics and retinoids.

article thumbnail

Burger with a Side of Phthalates: New Study Finds Harmful Chemicals in Fast Food Items

XTalks

The study , which was published last week in the Journal of Exposure Science & Environmental Epidemiology , showed that hormone-disrupting chemicals, known as phthalates, were prevalent in a wide range of fast-food items.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics

XTalks

In 2022, Januvia was flagged for nitrosamine contamination , a potential carcinogen commonly produced as a byproduct during drug manufacturing. for a pack of three pens, each containing 1.5 While sales remain strong, they have been on the decline. This led to a 15 percent drop in sales compared to the previous year. mL of 300 units/mL.

Sales 52
article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

announced that the EMA has validated for review the MAA for somatrogon, a long-acting recombinant human growth hormone intended to be administered once-weekly for the treatment of pediatric patients with growth hormone deficiency. Somatrogon — In February 2021, Pfizer and OPKO Health Inc.